Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 2
2021 2
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
The Relevance of Monoclonal Antibodies in the Treatment of COVID-19.
Torrente-López A, Hermosilla J, Navas N, Cuadros-Rodríguez L, Cabeza J, Salmerón-García A. Torrente-López A, et al. Among authors: hermosilla j. Vaccines (Basel). 2021 May 26;9(6):557. doi: 10.3390/vaccines9060557. Vaccines (Basel). 2021. PMID: 34073559 Free PMC article. Review.
Comprehensive physicochemical characterization of a peptide-based medicine: Teduglutide (Revestive®) structural description and stress testing.
Pérez-Robles R, Salmerón-García A, Hermosilla J, Torrente-López A, Clemente-Bautista S, Jiménez-Lozano I, Cabañas-Poy MJ, Cabeza J, Navas N. Pérez-Robles R, et al. Among authors: hermosilla j. Eur J Pharm Biopharm. 2023 Mar;184:103-115. doi: 10.1016/j.ejpb.2023.01.001. Epub 2023 Jan 18. Eur J Pharm Biopharm. 2023. PMID: 36669672 Free article.
Tracking the physicochemical stability of teduglutide (Revestive®) clinical solutions over time in different storage containers.
Pérez-Robles R, Hermosilla J, Navas N, Clemente-Bautista S, Jiménez-Lozano I, Cabañas-Poy MJ, Ruiz-Travé J, Hernández-García MA, Cabeza J, Salmerón-García A. Pérez-Robles R, et al. Among authors: hermosilla j. J Pharm Biomed Anal. 2022 Nov 30;221:115064. doi: 10.1016/j.jpba.2022.115064. Epub 2022 Sep 17. J Pharm Biomed Anal. 2022. PMID: 36152491 Free article.
Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes.
Navas N, Hermosilla J, Torrente-López A, Hernández-Jiménez J, Cabeza J, Pérez-Robles R, Salmerón-García A. Navas N, et al. Among authors: hermosilla j. J Pharm Anal. 2020 Dec;10(6):532-545. doi: 10.1016/j.jpha.2020.06.003. Epub 2020 Jun 26. J Pharm Anal. 2020. PMID: 32837741 Free PMC article.